Related Experiment Video
Updated: Jun 2, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Rescue therapies for seizures.
Valeriya S Poukas1, John R Pollard, Christopher Todd Anderson
1Penn Epilepsy Center, Department of Neurology, University of Pennsylvania, HUP, Philadelphia, PA 19104, USA.
Rescue therapies offer rapid seizure control for epilepsy patients who experience breakthrough seizures despite daily medication. These treatments, including medications and devices, can be administered as needed to stop seizures or manage emergencies like status epilepticus.
Area of Science:
- Neurology
- Pharmacology
- Medical Devices
Background:
- Epilepsy treatment often involves daily oral medications, but many patients still experience seizures.
- Existing therapies may not fully control seizure activity, necessitating alternative treatment strategies.
Purpose of the Study:
- To review currently available and emerging rescue therapies for epilepsy.
- To discuss pharmacologic and non-pharmacologic interventions for seizure management.
Main Methods:
- Review of US Food and Drug Administration (FDA) approved and nonapproved drugs.
- Examination of nonpharmacologic behavioral treatments.
- Inclusion of device-based therapies like vagus nerve stimulation and NeuroPace RNS® System.
Main Results:
- Rescue therapies provide rapid intervention for seizures, including seizure clusters and status epilepticus.
- These therapies benefit patients who can self-administer, caregivers, and those experiencing emergencies.
- A range of FDA-approved and non-FDA-approved options, alongside devices, are available or in development.
Conclusions:
- Rescue therapies are crucial for managing breakthrough seizures and emergencies in epilepsy.
- Both pharmacologic and non-pharmacologic approaches, including advanced devices, offer therapeutic benefits.
- Ongoing research and development continue to expand options for seizure abortant therapy.
More Related Videos
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
10:25Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
Published on: March 27, 2021
Related Concept Videos
Electroconvulsive Therapy
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...